CN101649313B - 一株重组毕赤酵母菌株的应用 - Google Patents
一株重组毕赤酵母菌株的应用 Download PDFInfo
- Publication number
- CN101649313B CN101649313B CN2009100627197A CN200910062719A CN101649313B CN 101649313 B CN101649313 B CN 101649313B CN 2009100627197 A CN2009100627197 A CN 2009100627197A CN 200910062719 A CN200910062719 A CN 200910062719A CN 101649313 B CN101649313 B CN 101649313B
- Authority
- CN
- China
- Prior art keywords
- bacterial strain
- pichia pastoris
- enzyme
- people
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000235058 Komagataella pastoris Species 0.000 title claims abstract description 47
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 39
- 230000000694 effects Effects 0.000 claims abstract description 11
- 210000004185 liver Anatomy 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims description 39
- 108090000790 Enzymes Proteins 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 26
- 239000012153 distilled water Substances 0.000 claims description 21
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims description 20
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims description 20
- 241000235648 Pichia Species 0.000 claims description 19
- 229920001661 Chitosan Polymers 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 13
- 238000013019 agitation Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- 239000003292 glue Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 4
- 239000001488 sodium phosphate Substances 0.000 claims description 4
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 4
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 4
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 4
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- -1 polyoxyethylene Polymers 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 208000007848 Alcoholism Diseases 0.000 abstract description 3
- 201000007930 alcohol dependence Diseases 0.000 abstract description 3
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 244000005700 microbiome Species 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 description 26
- 241000699666 Mus <mouse, genus> Species 0.000 description 25
- 239000000047 product Substances 0.000 description 22
- 108010093096 Immobilized Enzymes Proteins 0.000 description 20
- 239000000725 suspension Substances 0.000 description 16
- 108091008146 restriction endonucleases Proteins 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 238000013016 damping Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 6
- 230000028527 righting reflex Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102000003960 Ligases Human genes 0.000 description 5
- 108090000364 Ligases Proteins 0.000 description 5
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 5
- 230000005611 electricity Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 206010003084 Areflexia Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 102000003929 Transaminases Human genes 0.000 description 4
- 108090000340 Transaminases Proteins 0.000 description 4
- 229930003756 Vitamin B7 Natural products 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000008057 potassium phosphate buffer Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011735 vitamin B7 Substances 0.000 description 4
- 235000011912 vitamin B7 Nutrition 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000006196 deacetylation Effects 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 238000002205 phenol-chloroform extraction Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 2
- 102100036826 Aldehyde oxidase Human genes 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 235000006149 Eugenia stipitata Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241001074363 Zaedyus Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 101150095787 ldh2 gene Proteins 0.000 description 1
- 101150100271 ldhb gene Proteins 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 101150076304 spp gene Proteins 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100627197A CN101649313B (zh) | 2009-06-16 | 2009-06-16 | 一株重组毕赤酵母菌株的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100627197A CN101649313B (zh) | 2009-06-16 | 2009-06-16 | 一株重组毕赤酵母菌株的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101649313A CN101649313A (zh) | 2010-02-17 |
CN101649313B true CN101649313B (zh) | 2011-05-04 |
Family
ID=41671639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100627197A Active CN101649313B (zh) | 2009-06-16 | 2009-06-16 | 一株重组毕赤酵母菌株的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101649313B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2910271A1 (en) * | 2013-04-23 | 2014-10-30 | Nizyme, Inc. | Aldh2 for treatment of toxicity associated with an aldh2 deficiency |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101173226A (zh) * | 2007-10-22 | 2008-05-07 | 中国农业大学 | 一种巴斯德毕赤酵母重组菌及其应用 |
-
2009
- 2009-06-16 CN CN2009100627197A patent/CN101649313B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101173226A (zh) * | 2007-10-22 | 2008-05-07 | 中国农业大学 | 一种巴斯德毕赤酵母重组菌及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101649313A (zh) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102076741B (zh) | 生物量加工 | |
Rabelo et al. | Industrial waste recovery | |
CN106387398A (zh) | 一种促进仔猪生长发育并增强机体免疫力的饲料酵母添加剂及其制备方法 | |
CN105886423A (zh) | 生物发酵米糠粕的制备方法 | |
CN101457206B (zh) | 一种酸性木聚糖酶xyl10a及其基因和应用 | |
CN102757947A (zh) | 一种热稳定性改良的木聚糖酶xyn-CDBFV-m及其基因和应用 | |
CN105961839A (zh) | 一种秸秆饲料的制备方法 | |
CN101649323B (zh) | 按毕赤酵母偏爱密码子设计人乙醛脱氢酶2序列的方法 | |
Hu et al. | Conversion of yellow wine lees into high-protein yeast culture by solid-state fermentation | |
CN101649313B (zh) | 一株重组毕赤酵母菌株的应用 | |
CN101649297B (zh) | 一株重组毕赤酵母菌株及其筛选方法 | |
CN104862290A (zh) | 一种1,3-1,4-β-葡聚糖酶突变体 | |
CN101838636B (zh) | 一种高比活木聚糖酶xyn11f63及其基因和应用 | |
CN106591350A (zh) | 一种能降解纤维素生产益生纤维寡糖并分泌抗菌肽的多功能酿酒酵母 | |
CN103849607B (zh) | 耐高温植酸酶及其用途 | |
CN1847400A (zh) | 改良的高比活木聚糖酶及其基因、包括该基因的表达载体和重组酵母细胞以及表达方法 | |
CN101684475A (zh) | 重组毕赤酵母工程菌的构建及其应用 | |
CN101348776B (zh) | 分泌酸性纤维素酶的转基因乳酸菌及其制备方法和应用 | |
CN102992865A (zh) | 一种香菇用香根草栽培基质 | |
CN102987057B (zh) | 一种通过微生物发酵生产生物鱼粉的方法 | |
CN106666076A (zh) | 一种适用于发酵金针菇渣和啤酒糟的菌种组合物及其应用 | |
CN106244383B (zh) | 一种降低黄酒中生物胺含量的集成处理方法 | |
CN104799016A (zh) | 一种生物复合酶及其制备方法 | |
CN104171289B (zh) | 利用肉苁蓉药渣制备菌体蛋白的方法 | |
CN103756988B (zh) | 一种内切β-1,4-木聚糖酶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WUHAN HUAYUAN SCIENCE AND TECHNOLOGY DEVELOPMENT I Free format text: FORMER OWNER: WUHAN INSTITUTE OF TECHNOLOGY Effective date: 20130108 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130108 Address after: 430074 Hubei Province, Wuhan city Hongshan District No. 62 zhuodao Quan Lu Patentee after: Wuhan Institute of Industrial Science and Technology Development Corporation Address before: 430074 Wuhan, Hongshan Province District, hung Chu street, No. 693 Patentee before: Wuhan Institute of Technology |
|
CP03 | Change of name, title or address |
Address after: 430014 999 new high tech Avenue, East Lake New Technology Development Zone, Wuhan, Hubei Patentee after: Wuhan Hua Yuan Science and Technology Ltd. Address before: 430074 No. 62 Zhuodaoquan Road, Hongshan District, Wuhan City, Hubei Province Patentee before: Wuhan Institute of Industrial Science and Technology Development Corporation |
|
CP03 | Change of name, title or address |